SRx Health Solutions Inc.: A New Era in Health and Wellness

• The company underwent a stock split and rebranding, transitioning from Better Choice Company (BTTR) to SRx Health Solutions Inc. (SRXH) on the NYSE American stock market.
• This strategic shift follows a merger aimed at positioning SRx Health Solutions Inc. as a leader in the global health and wellness sector.
• Shareholders of the former Better Choice Company do not need to take any action, ensuring a seamless transition to SRx Health Solutions Inc.

On April 30, 2025, Better Choice Company, Inc., known for its focus on health and wellness, underwent a significant transformation. The company, previously trading under the ticker BTTR, executed a stock split, exchanging 20 shares for every 27 shares held. This move coincided with a rebranding effort, as the company officially changed its name to SRx Health Solutions Inc. and began trading under the new ticker symbol ‘SRXH’ on the NYSE American stock market.

The stock split and rebranding are part of a strategic shift following a business combination between Better Choice Company and SRx Health. This merger aims to position the newly formed SRx Health Solutions Inc. as a leader in the global health and wellness sector. The company is committed to providing top-tier products and solutions for pets, people, and families, enhancing its market presence and competitive edge.

Shareholders of the former Better Choice Company do not need to take any action due to these changes. The transition to SRx Health Solutions Inc. is designed to be seamless, ensuring that current investors experience minimal disruption. The company continues to be listed on the AMEX exchange, maintaining its visibility and accessibility to investors.

SRx Health Solutions Inc. is recognized as an integrated Canadian healthcare services provider, operating within the specialty healthcare industry. This strategic focus allows the company to leverage its expertise and resources to deliver innovative health solutions. The merger and rebranding are expected to strengthen its position in the market, offering enhanced value to its stakeholders.

Better Choice Company Inc. (AMEX:BTTR) operates in the competitive pet food industry, focusing on premium pet food products. Despite facing stiff competition, BTTR's recent financial performance reveals some positive developments alongside challenges. On March 27, 2025, BTTR reported an earnings per share (EPS) of -$0.50, surpassing the estimated -$4.84 significantly. However, the company's revenue of $7.2 million did not meet the expected $12.9 million.

During the Q4 2024 earnings call, CEO Kent Cunningham and CFO Nina Martinez discussed BTTR's financial outcomes. The improvement in EPS suggests positive internal developments, yet the revenue shortfall underscores difficulties in aligning with market expectations.

BTTR's financial ratios present a nuanced view of its fiscal health. The negative price-to-earnings (P/E) ratio of approximately -0.29 signals current unprofitability, while a price-to-sales ratio of 0.11 reflects low market valuation of its sales. The enterprise value to sales ratio stands at a negative -0.03, and the enterprise value to operating cash flow ratio is -1.01, both indicating revenue generation and cash flow challenges. Moreover, a negative earnings yield of -3.46% further emphasizes profitability issues.

Conversely, BTTR's low debt-to-equity ratio of 0.008 indicates a minimal reliance on debt, suggesting a cautious approach to leveraging. Additionally, a current ratio of 2.38 demonstrates BTTR's capability to cover its short-term liabilities, highlighting a solid liquidity position.

Better Choice Company Inc. (AMEX:BTTR) operates in the competitive pet food industry, focusing on premium pet food products. Despite facing stiff competition, BTTR's recent financial performance reveals some positive developments alongside challenges. On March 27, 2025, BTTR reported an earnings per share (EPS) of -$0.50, surpassing the estimated -$4.84 significantly. However, the company's revenue of $7.2 million did not meet the expected $12.9 million.

During the Q4 2024 earnings call, CEO Kent Cunningham and CFO Nina Martinez discussed BTTR's financial outcomes. The improvement in EPS suggests positive internal developments, yet the revenue shortfall underscores difficulties in aligning with market expectations.

BTTR's financial ratios present a nuanced view of its fiscal health. The negative price-to-earnings (P/E) ratio of approximately -0.29 signals current unprofitability, while a price-to-sales ratio of 0.11 reflects low market valuation of its sales. The enterprise value to sales ratio stands at a negative -0.03, and the enterprise value to operating cash flow ratio is -1.01, both indicating revenue generation and cash flow challenges. Moreover, a negative earnings yield of -3.46% further emphasizes profitability issues.

Conversely, BTTR's low debt-to-equity ratio of 0.008 indicates a minimal reliance on debt, suggesting a cautious approach to leveraging. Additionally, a current ratio of 2.38 demonstrates BTTR's capability to cover its short-term liabilities, highlighting a solid liquidity position.